Leslie Harris BRAIL

Person

Newton, MA, US

People

Patents Applicationslast 30 patents

Information Patent Application
USES OF TRI-SUBSTITUTED HETEROARYL DERIVATIVES AS SRC HOMOLOGY-2 PH...
- Publication number 20240415843
- Publication date Dec 19, 2024
- Erasca, Inc.
- Leslie Harris BRAIL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK1/2 AND EGFR INHIBITORS COMBINATION THERAPY
- Publication number 20240307392
- Publication date Sep 19, 2024
- Erasca, Inc.
- Robert Field SHOEMAKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK1/2 AND SHP2 INHIBITORS COMBINATION THERAPY
- Publication number 20240299388
- Publication date Sep 12, 2024
- Erasca, Inc.
- Robert Field SHOEMAKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT...
- Publication number 20240293422
- Publication date Sep 5, 2024
- Erasca, Inc.
- Leenus MARTIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ERK1/2 OR SHP2 INHIBITORS AND FLT3 INHIBITORS COMBINATION THERAPY
- Publication number 20240285624
- Publication date Aug 29, 2024
- Erasca, Inc.
- Robert Field SHOEMAKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
- Publication number 20240058352
- Publication date Feb 22, 2024
- Erasca, Inc.
- Leenus MARTIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
- Publication number 20240050441
- Publication date Feb 15, 2024
- Erasca, Inc.
- Leenus MARTIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Leslie Harris BRAIL

Person

Patents Applicationslast 30 patents

USES OF TRI-SUBSTITUTED HETEROARYL DERIVATIVES AS SRC HOMOLOGY-2 PH...

ERK1/2 AND EGFR INHIBITORS COMBINATION THERAPY

ERK1/2 AND SHP2 INHIBITORS COMBINATION THERAPY

SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT...

ERK1/2 OR SHP2 INHIBITORS AND FLT3 INHIBITORS COMBINATION THERAPY

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER